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Abstract
The hexammineruthenium (HAR) and ferricyanide reductase activities of Complex I (H-translocating NADH:ubiqui-
none reductase) from Paracoccus denitrificans and bovine heart mitochondria were studied. The rates of HAR reduction are
high, and its steady-state kinetics is similar in both P. denitrificans and bovine Complex I. The deamino-NADH:HAR
reductase activity of Complex I from both sources is significantly higher than the respective activity in the presence of
NADH. The HAR reductase activity of the bacterial and mitochondrial Complex I is similarly and strongly pH dependent.
The pKa of this activity could not be determined, however, due to low stability of the enzymes at pH values above 8.0. In
contrast to the high similarity between bovine and P. denitrificans Complex I as far as HAR reduction is concerned, the
ferricyanide reductase activity of the bacterial enzyme is much lower than in mitochondria. Moreover, ferricyanide reduction
in P. denitrificans, but not bovine mitochondria, is partially sensitive to dicyclohexylcarbodiimide (T. Yagi, Biochemistry 26
(1987) 2822^2828). On the other hand, the inhibition of ferricyanide reduction by high concentration of NADH, a typical
phenomenon in bovine Complex I, is much weaker in the bacterial enzyme. The functional differences between the two
enzymes might be linked to the properties of their binuclear Fe^S clusters. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
The H-translocating NADH:ubiquinone oxidore-
ductase (Complex I) is a very large enzyme that com-
prises the ¢rst segment of the respiratory chain in
most eukaryotes and many bacteria. Bovine mito-
chondrial Complex I is composed of some 43 di¡er-
ent protein subunits, seven of which are encoded and
synthesized within the organelle. The redox centers
of the enzyme include one FMN molecule, probably
two binuclear Fe^S clusters, and ¢ve or six tetranu-
clear Fe^S clusters [1,2]. Bacterial Complex I (also
called NDH-1) contains a similar set of redox cen-
ters, but ‘only’ 14 di¡erent protein subunits. Seven of
these 14 subunits are homologues of the mitochon-
drially encoded subunits in eukaryotic Complex I,
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and the other seven are homologous to seven of the
nuclear-encoded subunits that play central roles in
the structure and function of the enzyme [3^5].
NDH-1 of the soil bacterium Paracoccus denitri¢-
cans is highly similar to bovine (and human) Com-
plex I with respect to the primary structure of its 14
subunits [3,6], and the physicochemical properties of
most of its Fe^S clusters [7^9]. However, the two
binuclear Fe^S clusters of Complex I may represent
exceptions to this rule. The midpoint redox potential
of cluster N1-a in bovine heart Complex I is very
low, 3370 mV at pH 7.0 and 3430 mV at pH 8.0
[9,10], or even lower [11]. Since the midpoint poten-
tial of the NADH/NAD couple is higher, 3320
mV, it is unclear whether or not cluster N1-a partic-
ipates in electron transfer reactions within the en-
zyme. In P. denitri¢cans, on the other hand, the mid-
point potential of cluster N1-a is higher than the
potential of most of the tetranuclear Fe^S clusters,
except cluster N-2 [8]. The main question regarding
the other binuclear cluster, N1-b, is its stoichiometry
in bovine Complex I. Albracht and co workers have
calculated that cluster N1-b is present in bovine
Complex I at only half the amount of the other re-
dox centers [12]. Interestingly, work from the same
laboratory suggest that the concentration of cluster 1
(presumably N1-b) in P. denitri¢cans Complex I is
higher than in bovine Complex I, i.e. in the bacterial
enzyme it is similar to the concentration of FMN
and the tetranuclear Fe^S clusters [7].
Complex I can catalyze rotenone-insensitive reduc-
tion of ferricyanide, and this activity has been widely
used as a convenient assay during puri¢cation of the
enzyme or fragments thereof [13^16]. Ferricyanide
reduction is inhibited by high concentrations of ei-
ther NADH or ferricyanide, a phenomenon called
double substrate inhibition [17,18]. In spite of this
substrate inhibition, the ferricyanide reductase activ-
ity was often used in the past for kinetic studies on
the NADH oxidation site of bovine Complex I
[17,18].
Hexammineruthenium (HAR) is a water-soluble
acceptor that supports high rate of NADH oxidation
by Complex I, and in contrast to ferricyanide, its
reduction is not inhibited by NADH [19]. Both fer-
ricyanide and HAR reduction are also catalyzed by
the £avoprotein fragment of Complex I (FP) that
contains only the 51-, 24- and 10-kDa subunits
[20]. The FP contains FMN and some iron and in-
organic sulfur [14]. It is unclear, however, if intact
Fe^S clusters are present in this fragment [11,21],
and whether they are needed for either ferricyanide
or HAR reduction.
Deamino-NADH is a NADH analogue in which
the adenine moiety is replaced by hypoxanthine. The
small NADH:ubiquinone reductase of Escherichia
coli, NDH-2, does not oxidize deamino-NADH,
but for NDH-1 this compound is a good electron
donor [22]. Nonetheless, the e¡ect of that di¡erence
in the donor structure on the kinetics of its binding
and oxidation by NDH-1 has not been examined,
yet.
The e¡ects of dicyclohexylcarbodiimide (DCCD)
on the activity of mitochondrial and bacterial Com-
plex I have been studied [23^25]. In bovine mito-
chondrial and bacterial Complex I from Escherichia
coli and Thermus thermophilus, DCCD inhibited ubi-
quinone reduction, but not ferricyanide reduction. In
P. denitri¢cans, on the other hand, the ferricyanide
reductase activity was also sensitive to DCCD [23].
The reasons for that unusual sensitivity have not
been clari¢ed.
We have studied the HAR and ferricyanide reduc-
tase activities of P. denitri¢cans and bovine Complex
I. The kinetics of the reactions, their dependencies on
pH, sensitivities to DCCD, and the e¡ect of donor
type on the activity have been carefully examined.
Our ¢ndings indicate that in spite of the high simi-
larity between P. denitri¢cans and bovine Complex I,
there are clear di¡erences between them at the elec-
tron input site of the enzyme.
2. Materials and methods
2.1. Materials
Ubiquinone-1 (Q1) was a generous gift from Hof-
mann-La Roche, Switzerland. DCCD was purchased
from Merck, rotenone and hexammineruthenium
from Aldrich, NADH from Boehringer, and ferricya-
nide and deamino-NADH from Sigma.
2.2. Preparative procedures
P. denitri¢cans strain F2 was grown under high
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aeration in a malate-containing medium. Membranes
were prepared from mid-log phase cells as described
previously [26]. Mitochondrial membranes from bo-
vine heart were prepared as previously described [27].
2.3. Activity assays
Enzymatic activities were assayed at 30‡C. The
oxidation rate of NADH or deamino-NADH in the
presence of HAR was monitored spectrophotometri-
cally at 340 nm, or at 380 nm in cases of high
NADH concentrations. The HAR reductase activity
was carried out as described previously [26], and the
reduction of ferricyanide was assayed according to
Minakami et al. [17], but in the presence of 5 mM
KCN (neutralized with HCl) and 15 WM rotenone.
The pH dependency of the activities was assayed in
the presence of 50 mM potassium phosphate of ap-
propriate pH. The concentrations of the di¡erent
substrates in these experiments (Fig. 3) were as fol-
low: (1) HAR reductase activity, 2 mM HAR,
0.3 mM NADH or deamino-NADH; (2) Q1 reduc-
tase activity, 60 WM Q1, 0.2 mM NADH or deamino-
NADH, rotenone and KCN as described above,
1 mg/ml sonicated phospholipid [26] and 2.5 Wg/ml
antimycin A; and (3) ferricyanide reductase activity,
0.45 mM ferricyanide and 0.1 mM NADH or dea-
mino-NADH.
2.4. DCCD inhibition
Membrane samples of either P. denitri¢cans or bo-
vine heart mitochondria were diluted to 1 mg/ml
protein in a solution containing 1 mg/ml sonicated
phospholipid, 250 mM sucrose and 50 mM potassi-
um phosphate, pH 7.0, and placed on ice. DCCD
was added from an ethanolic solution to a ¢nal con-
centration of 0.8 mM, and corresponding amounts of
cold solvent were added to the control sample. The
samples were exposed to the inhibitor for 16 h at
0‡C, and special care was taken to maintain the tem-
perature of the samples very close to 0‡C for the
entire incubation. The activity measurements in-
volved a 1:50 dilution of the sample into the assay
medium, and thus the DCCD concentration in the
assay cuvette was too low to inhibit the activity dur-
ing the few min at 30‡C, as was shown in separate
experiments.
Protein concentrations were determined according
to Lowry et al. [28], in the presence of 0.2% SDS.
3. Results and discussion
Complex I is composed of many protein subunits
and redox centers. The bacterial enzyme from P. de-
nitri¢cans provides a good model system for mito-
chondrial Complex I, and it has recently been used
in site-directed mutagenesis studies on the putative
ubiquinone binding site of the enzyme [26]. Nonethe-
less, the kinetic properties of P. denitri¢cans Com-
plex I, or any other such bacterial enzyme, have not
yet been carefully examined. Characterization of en-
zymatic activities and their kinetics is important for a
better understanding of the enzyme’s function. In
addition, this may help to determine which kinetic
properties of Complex I are fundamental for its ac-
tivity, and which mainly represent minor di¡erences
between species.
The tetranuclear, EPR-detectable, Fe^S clusters of
P. denitri¢cans and bovine Complex I appeared to be
highly similar with respect to their line shape and
midpoint potential [7^9]. On the other hand, di¡er-
ences were observed between the two enzyme in the
stoichiometry [7], or midpoint potential [8] of the
binuclear Fe^S clusters. The two binuclear Fe^S clus-
ters of Complex I, N1-a and N1-b, are most likely
bound within the NADH dehydrogenase fragment of
Complex I, i.e. one in the 24-kDa subunit (called
NQO2 or NUOE in bacteria), and the other in the
N-terminal segment of the 75-kDa subunit (NQO3
or NUOG) [3]. Hence, di¡erences between P. deni-
tri¢cans and bovine Complex I in activities that are
catalyzed in the vicinity of the NADH oxidation do-
main could be the result of the di¡erent properties of
their respective binuclear clusters.
In order to address this question, we have studied
the rotenone-insensitive reduction of ferricyanide and
HAR, using bacterial and mitochondrial Complex I
in their native membranes. The concentration of
Complex I in P. denitri¢cans membranes may depend
on the growth conditions of the culture, and the
degree of cell wall removal during membrane isola-
tion. Due to this possible sample variability we took
care to use the same membrane preparation when-
ever the di¡erent activities were analyzed on the basis
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of protein concentration in the membrane. In other
cases it was assumed that the HAR reductase activity
is the best available estimate for the concentration of
Complex I in the membrane, and it was used as a
reference [26].
The speci¢c HAR reductase activity of P. denitri-
¢cans Complex I in the membrane preparations was
similar to the mitochondrial enzyme (Fig. 1). The
speci¢c ferricyanide reductase activity of P. denitri¢-
cans Complex I is, however, much lower than in
mitochondria (Fig. 1). Furthermore, the typical sub-
strate inhibition of the ferricyanide reductase activity
of Complex I by high concentration of NADH (e.g.
Fig. 1A, traces 3 and 4) is hardly detectable for P.
denitri¢cans Complex I at the lower ferricyanide con-
centration (Fig. 1B, trace 4). Even at higher ferricya-
nide concentration, the substrate inhibition by
NADH is clearly less than in bovine Complex I
(trace 3 in Fig. 1A,B). These observations, namely
the low ferricyanide reductase activity in comparison
to the HAR reductase activity, and the absence of
strong substrate inhibition by NADH, suggest that
in functional terms the NADH dehydrogenase do-
main of P. denitri¢cans may be di¡erent from the
bovine enzyme. This conclusion came as a surprise
since P. denitri¢cans Complex I is highly homologous
to the mitochondrial enzyme in many respects [3,6^
9].
Sled and Vinogradov [19] have investigated the
kinetics of the HAR reductase activity of bovine
complex I, and found that it deviates from simple
Michaelis^Menten kinetics [19]. They determined
Ksapp values for NADH of 10 and 40 WM for iso-
lated and membrane-bound Complex I, respectively,
by extrapolation to zero acceptor concentration on a
secondary plot of Km vs. Vmax [19]. We have ana-
lyzed kinetic data for P. denitri¢cans Complex I in
a similar way and the results are presented in Fig. 2.
The double reciprocal plots yield a series of straight
lines that intercept in the third quadrant (Fig. 2A), as
has been observed for bovine Complex I [19]. The
Ksapp value for NADH, determined from the data
Fig. 1. Dependence of the ferricyanide and HAR reductase activities of Complex I on NADH concentration. Membrane-bound en-
zymes from bovine heart mitochondria (A) and P. denitri¢cans (B) were examined. The acceptor concentrations were 2 mM HAR (1),
0.5 mM HAR (2), 0.9 mM ferricyanide (3) or 0.45 mM ferricyanide (4). The activity is expressed as Wmol NADH oxidized min31
(mg membrane protein)31.
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for P. denitri¢cans Complex I, is 26 WM (Fig. 2B), i.e.
almost the same as for bovine Complex I. It may
thus be concluded that as far as the rates and kinetics
of the HAR reductase activity are concerned P. de-
nitri¢cans Complex I is practically identical to the
mitochondrial enzyme.
In our studies of P. denitri¢cans Complex I mu-
tants it was often necessary to use deamino-NADH
as the electron donor instead of NADH in order to
eliminate NDH-2 activity from the assays [26]. We
have now asked how similar deamino-NADH is to
NADH with respect to the di¡erent activities of
Complex I. In addition, we have examined the pH
dependencies of these activities in the range of 6.5 to
8.0. These two assays were combined, and the results
are presented in Fig. 3. The HAR reductase activity
of Complex I of both P. denitri¢cans and bovine is
pH dependent, regardless of whether the donor is
NADH or deamino-NADH (Fig. 3A). However,
the donor type had a marked e¡ect on the rate of
the reaction, and for both enzymes deamino-NADH
was oxidized faster than NADH when the acceptor
was HAR (Fig. 3A). The dependence of the HAR
reductase activity on pH in both P. denitri¢cans and
bovine Complex I (Fig. 3A) may suggest that depro-
tonation of a speci¢c group close to the FMN is
important for binding the positively charged accep-
tor, HAR. This is in agreement with previous work
where positively charged ions were shown to inhibit
the activity [20]. The observed di¡erence in rate be-
tween NADH as compared to deamino-NADH (Fig.
3A) may also be interpreted according to the kinetics
model that was suggested by Gavrikova and co-
workers [20]. Thus, replacement of the amino group
in NADH with a carbonyl oxygen in deamino-
NADH changes the local charge in this area of the
donor molecule, and may accelerate its binding to
the pre-formed protein^HAR complex.
The pH dependence of the rotenone-sensitive Q1
reductase activity is very di¡erent from HAR reduc-
tion, and a clear optimum was visible in each experi-
ment (Fig. 3B). These reactions are slower and much
more complex than HAR or ferricyanide reduction,
hence the similarity between the two enzymes mainly
re£ects Q1 binding or the rate-limiting step(s) of elec-
tron transfer reactions within the enzyme. The latter
Fig. 2. (A) A double reciprocal plot of the NADH:HAR oxidoreductase activity of NDH-1 from P. denitri¢cans. NADH titrations
were performed in the presence of the indicated HAR concentrations. (B), secondary plot of the Km and Vmax values, and extrapola-
tion to zero acceptor concentration in order to determine Ksapp for NADH.
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is not expected to be electron transfer from NADH
to FMN since the rates of HAR reduction in both
enzymes are about 10 times higher than the reduc-
tion of Q1 (Fig. 3A). Thus, it is di⁄cult to explain
the small, but reproducible, lower pH optimum for
NADH oxidation in comparison to deamino-NADH
oxidation by Q1 (Fig. 3B). This ¢nding might be
related to coordinated redox reactions that involve
other redox centers within Complex I, and should
be studied further.
The ferricyanide reductase activity, in contrast to
HAR and Q1 reductions, exhibits very little depen-
dence on pH in the tested range (Fig. 3C). A depen-
dence on donor type was detectable, however, and
the rate of ferricyanide reduction was higher in the
presence of NADH than with deamino-NADH (Fig.
3C). The same holds for the bacterial enzyme, even
though the scale of the ¢gure makes it di⁄cult to
observe the small di¡erences between the NADH
and deamino-NADH oxidation rates in P. denitri¢-
cans. Taken together with the HAR and Q1 reduc-
tase activities, it may be suggested that the large rate
di¡erence in ferricyanide reduction between P. deni-
tri¢cans and bovine Complex I is primarily due to
lower a⁄nity of ferricyanide for the bacterial en-
zyme, and not due to di¡erences between the mam-
malian and prokaryotic Complex I in the primary
events of NADH binding and oxidation.
The e¡ect of DCCD inhibition on the activities of
mitochondrial Complex I [23^25], and bacterial
NDH-1 from P. denitri¢cans, E. coli and T. thermo-
philus have been previously studied [23]. It was ob-
served that in P. denitri¢cans Complex I, the ferri-
cyanide reductase activity is sensitive to DCCD,
although to a lower extent than the Q1 reductase
activity [23]. It may be noted that in that work, the
ferricyanide reductase activity present in P. denitri¢-
cans membranes was much higher than the Q1 reduc-
tion, and that the ratio between these rates was sim-
ilar to the ratio in bovine heart membranes [23]. This
Fig. 3. The pH dependence of NADH and deamino-NADH oxidation in the presence of di¡erent acceptors. The HAR and ferricya-
nide activities are rotenone-insensitive (assayed in the presence of rotenone, see Section 2). In assays of the Q1 reductase activity, the
rotenone-insensitive activity (about 10%) was subtracted, and only the rotenone-sensitive activity is presented. Note that the scale of
enzyme activity is di¡erent in each panel of the ¢gure. Solid lines represent bovine Complex I in mitochondrial membranes, and
dashed lines represent P. denitri¢cans Complex I in the bacterial membranes. NADH oxidation is marked by diamonds (bovine) or
triangles (P. denitri¢cans), and deamino-NADH oxidation by squares (mitochondria) and circles (bacteria).
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result is contradictory to our ¢ndings (Figs. 1 and 3),
and it is probably due to the absence of rotenone (or
antimycin A) during the assays [23]. It is likely that
under such conditions, ferricyanide was mainly re-
duced through the cytochrome bc1 complex rather
than Complex I. Due to this discrepancy, we have
re-examined DCCD inhibition in bovine and P. de-
nitri¢cans Complex I, and the results are summarized
in Table 1.
The DCCD inhibition results reinforce the notion
that the ferricyanide reductase activity of P. denitri-
¢cans Complex I is di¡erent from the activity of the
mitochondrial enzyme (Table 1). This stands in sharp
contrast to the HAR reductase activity that appears
to be highly similar between the two enzymes (Figs.
1^3 and Table 1). The small percent inhibition of the
HAR reductase activity in both systems, up to about
10%, appears to be within the variation of measure-
ment method. However, the inhibition of the rote-
none-insensitive ferricyanide reduction in P. denitri-
¢cans appears to be signi¢cant, if only partial. The
DCCD inhibition may be related to the slow rate of
ferricyanide reduction in P. denitri¢cans Complex I.
The electron transfer to ferricyanide is not very e⁄-
cient and hence a small conformational change that
may be caused by DCCD binding somewhere else in
the enzyme, might be su⁄cient to further reduce the
rate of ferricyanide reduction. Another possibility is
that there is a DCCD binding site inside the NADH
oxidation domain in P. denitri¢cans Complex I. Such
a possibility is currently being investigated in our
laboratory.
The ferricyanide reductase activity of bovine Com-
plex I has been extensively studied ([29] and referen-
ces therein). A characteristic feature of this activity is
its sensitivity to high concentrations of either the
donor, NADH, or the acceptor, ferricyanide
[17,18]. This inhibition by high concentrations of do-
nor and acceptor was taken to indicate that the fer-
ricyanide reduction is catalyzed by a ping-pong
mechanism, whereby NADH and ferricyanide are
competing with each other for access to the FMN,
which is most likely buried inside the protein [18,29].
The results of the present study may suggest that in
P. denitri¢cans Complex I, such a competition does
not take place, except possibly, at very high ferricya-
nide concentrations (Fig. 1B). One possible explana-
tion for the lack of substrate inhibition may be
that while the access of ferricyanide to the FMN in
this bacterial enzyme is restricted, the passage of
NADH to its oxidation site is fast and similar to
the situation in bovine Complex I. Alternatively,
the access of ferricyanide to the £avin pocket in
P. denitri¢cans may not be di¡erent from that in
bovine Complex I, but its reduction rate in the bac-
terial enzyme may be much slower. In any case, the
results of this work clearly show that the two en-
zymes di¡er in their ferricyanide reductase activity,
but not in other activities that are catalyzed by the
NADH oxidation domain of Complex I. This is a
surprising ¢nding when the high homologies between
the two enzymes are considered, and it may point to
the involvement of at least one of the binuclear Fe^S
clusters in ferricyanide reduction. One may speculate
that the presence of an oxidized Fe^S cluster in the
vicinity of the £avin stabilizes the state of FMN
that can reduce ferricyanide readily. The higher po-
tential of this cluster in P. denitri¢cans may mean
that it is reduced under the assay conditions and
thus does not stimulates ferricyanide reduction. Fu-
Table 1
The e¡ect of DCCD on Complex I activities in membranes from P. denitri¢cans and bovine heart mitochondria
Acceptor NADH:acceptor reductase activities (% of initial activity þ S.D.) after incubation in the presence or absence of
DCCD
P. denitri¢cans Bovine mitochondria
3DCCD +DCCD % inhibition 3DCCD +DCCD % inhibition
Q1 79.8 þ 3.4 13.2 þ 0.9 83.5 86.5 þ 2.3 31.9 þ 1.1 63.1
Ferricyanide 73.7 þ 4.1 50.9 þ 2.8 31.0 88.4 þ 1.4 81.0 þ 3.2 8.4
HAR 79.8 þ 3.0 74.3 þ 1.1 6.9 92.6 þ 2.2 84.0 þ 1.3 9.3
Membrane samples were incubated at 0‡C and pH 7.0 for 16 h in the presence or absence of 800 WM DCCD. Three parallel tubes
were used in each incubation. The percent activity values are in comparison to the respective activities at the onset of the incubations.
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ture experiments using site directed mutagenesis of
the bacterial subunits, NQO 1, 2 and 3 (NUO E, F
and G), may shed light on the mechanism of this
reaction.
One of the main ¢ndings of the present work is the
high similarity of the HAR reductase activity be-
tween mitochondrial and bacterial Complex I (Figs.
1^3 and Table 1). In light of the above discussion,
this result may suggest that the binuclear Fe^S clus-
ters of Complex I do not play a role in HAR reduc-
tion. This observation is in agreement with the ¢nd-
ing that the HAR reductase activity of the
£avoprotein fragment of bovine Complex I (FP) is
very similar to the activity of the intact enzyme [20].
It was earlier reported that although the FP fragment
contains iron and inorganic sulfur, it lacks a clear
EPR spectrum of intact Fe^S clusters [11,21,29].
Hence, if the Fe^S clusters in the vicinity of the
bound FMN have been destroyed during the isola-
tion of this fragment without signi¢cantly a¡ecting
HAR reduction [20], one can conclude that they are
not involved in this activity. Interestingly, the FP
fragment has a considerable ferricyanide reductase
activity per mg protein. However, if the activity is
calculated per bound FMN, it is about 10 times low-
er than in intact bovine Complex I [14,29].
Finally, the HAR reductase activity is a very use-
ful tool in studies on both isolated and membrane-
bound Complex I. This activity, at su⁄ciently high
concentrations of HAR and NADH, and even more
so deamino-NADH (Fig. 3), provides a sensitive tool
for detection and determination of small amounts of
Complex I, as we have recently demonstrated [26]. In
the future, this activity could be bene¢cial for de-
tailed studies on NADH binding and oxidation by
Complex I, and for analysis of Complex I mutants in
di¡erent organisms.
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